The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy
Abstract
Pharmacological use of ascorbate (vitamin C) enhanced chemosensitivity of ovarian cancer in preclinical models and reduced chemotherapy-associated toxicity in patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A significant number of human studies consistently show that ascorbate treatment improved quality of life for patients with cancer, and in combination therapy, ascorbate protected normal tissues from toxicity caused by chemotherapy114.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [114]
In the citing paper
“A significant number of human studies consistently show that ascorbate treatment improved quality of life for patients with cancer, and in combination therapy, ascorbate protected normal tissues from toxicity caused by chemotherapy114.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [114]
In the citing paper
“This paper shows in its preclinical and clinical studies that high-dose vitamin C can potentially increase the efficacy and reduce the toxicities of certain conventional chemotherapies when used in combination to treat patients with ovarian cancer.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [114]
Citations
Cites
1 retracted
Huang, Q. B., Wu, Y., Tan, H.-L., Ong, C.-N., & Shen, H.-M. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.151 · Cited by 116
RetractedA simple technique for quantitation of low levels of DNA damage in individual cells
Singh, N. P., McCoy, M. T., Tice, R. R., & Schneider, E. L. (1988) · Experimental Cell Research · doi:10.1016/0014-4827(88)90265-0 · Cited by 10,828
Chou, T.-C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.10 · Cited by 5,163
Rapid colorimetric assay for cell growth and survival
Denizot, F., & Lang, R. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90368-6 · Cited by 4,935
The metabolism of tumors in the body
Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416
Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance
Levine, M., Conry-Cantilena, C., Wang, Y., Welch, R. W., Washko, P. W., Dhariwal, K. R., Park, J. B., Lazarev, A., Graumlich, J. F., King, J., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3704 · Cited by 1,325
Self-citationChen, Q., Espey, M. G., Krishna, M. C., Mitchell, J. B., Corpe, C. P., Buettner, G. R., Shacter, E., & Levine, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506390102 · Cited by 1,075
Self-citationVitamin C pharmacokinetics: Implications for oral and intravenous use
Padayatty, S. J., Sun, H., Wang, Y., Riordan, H. D., Hewitt, S. M., Katz, A., Wesley, R. A., & Levine, M. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-7-200404060-00010 · Cited by 992
Self-citationChen, Q., Espey, M. G., Sun, A. Y., Pooput, C., Kirk, K. L., Krishna, M. C., Khosh, D. B., Drisko, J., & Levine, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804226105 · Cited by 854
Self-citationATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS
Alexander, A., Cai, S.-L., Kim, J., Nanez, A., Sahin, M., MacLean, K. H., Inoki, K., Guan, K.-L., Shen, J., Person, M. D., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913860107 · Cited by 717
Cited by
Sorted by citations
Fundamentals of Cancer Metabolism
DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013
ROS and the DNA damage response in cancer
Srinivas, U. S., Tan, B. W. Q., Vellayappan, B. A., & Jeyasekharan, A. D. (2019) · Redox Biology · doi:10.1016/j.redox.2018.101084 · Cited by 2,144
“On the other end of the spectrum, due to the diverse effects described above for ROS in activating various DNA damage responses, high ROS is also associated with resistance to chemotherapy [18,136].”
BackgroundAntioxidant and Oxidative Stress: A Mutual Interplay in Age-Related Diseases
Tan, B. L., Norhaizan, M. E., Liew, W.-P.-P., & Rahman, H. S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01162 · Cited by 1,221
Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH
Yun, J., Mullarky, E., Lu, C., Bosch, K. N., Kavalier, A., Rivera, K., Roper, J., Chio, I. I. C., Giannopoulou, E. G., Rago, C., et al. (2015) · Science · doi:10.1126/science.aaa5004 · Cited by 913
“xenograft models (37, 38), the mechanism by which vitamin”
BackgroundReactive oxygen species and cancer paradox: To promote or to suppress?
Galadari, S., Rahman, A. U., Pallichankandy, S., & Thayyullathil, F. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.004 · Cited by 918
Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases
Nakamura, T., Naguro, I., & Ichijo, H. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.06.010 · Cited by 529
Two Faces of Vitamin C—Antioxidative and Pro-Oxidative Agent
Kaźmierczak-Barańska, J., Boguszewska, K., Adamus-Grabicka, A., & Karwowski, B. T. (2020) · Nutrients · doi:10.3390/nu12051501 · Cited by 455
Schoenfeld, J. D., Sibenaller, Z. A., Mapuskar, K. A., Wagner, B. A., Cramer-Morales, K. L., Furqan, M., Sandhu, S., Carlisle, T. L., Smith, M. C., Abu Hejleh, T., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.018 · Cited by 443
Torti, S. V., Manz, D. H., Paul, B. T., Blanchette-Farra, N., & Torti, F. M. (2018) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-082117-051732 · Cited by 426
Targeting cancer vulnerabilities with high-dose vitamin C
Ngo, B., Van Riper, J. M., Cantley, L. C., & Yun, J. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0135-7 · Cited by 423
Doskey, C. M., Buranasudja, V., Wagner, B. A., Wilkes, J. G., Du, J., Cullen, J. J., & Buettner, G. R. (2016) · Redox Biology · doi:10.1016/j.redox.2016.10.010 · Cited by 301
Oxidative Stress in the Tumor Microenvironment and Its Relevance to Cancer Immunotherapy
Aboelella, N. S., Brandle, C., Kim, T., Ding, Z., & Zhou, G. (2021) · Cancers · doi:10.3390/cancers13050986 · Cited by 303
Iron and thiol redox signaling in cancer: an exquisite balance to escape ferroptosis
Toyokuni, S., Ito, F., Yamashita, K., Okazaki, Y., & Akatsuka, S. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.04.024 · Cited by 252
Ke, W., Li, J., Mohammed, F., Wang, Y., Tou, K., Liu, X., Wen, P., Kinoh, H., Anraku, Y., Chen, H., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b09082 · Cited by 254
Targeting EMT in Cancer with Repurposed Metabolic Inhibitors
Ramesh, V., Brabletz, T., & Ceppi, P. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.06.005 · Cited by 245
Drug-induced oxidative stress in cancer treatments: Angel or devil?
Jiang, H., Zuo, J., Li, B., Chen, R., Luo, K., Xiang, X., Lu, S., Huang, C., Liu, L., Tang, J., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102754 · Cited by 262
Antioxidants in Translational Medicine
Schmidt, H. H. H. W., Stocker, R., Vollbracht, C., Paulsen, G., Riley, D. P., Daiber, A., & Cuadrado, A. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6393 · Cited by 232
Vitamin C increases viral mimicry induced by 5-aza-2′-deoxycytidine
Liu, M., Ohtani, H., Zhou, W., Ørskov, A. D., Charlet, J., Zhang, Y. W., Shen, H., Baylin, S. B., Liang, G., Grønbæk, K., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612262113 · Cited by 225
High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer
Böttger, F., Vallés‐Martí, A., Cahn, L., & Jiménez, C. R. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02134-y · Cited by 223
Vitamin C in stem cell reprogramming and cancer
Cimmino, L., Neel, B. G., & Aifantis, I. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.04.001 · Cited by 197
Ascorbic Acid in Cancer Treatment: Let the Phoenix Fly
Shenoy, N. K., Creagan, E. T., Witzig, T. E., & Levine, M. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.07.014 · Cited by 208
Self-citationPotential Mechanisms of Action for Vitamin C in Cancer: Reviewing the Evidence
Vissers, M. C. M., & Das, A. B. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00809 · Cited by 188
“AscH− + Fe3+ → Asc•− + Fe2+ +H+ (1) Fe2+ +H2O2 +H+ → Fe3+ +H2O+HO• (2) The ability to reduce transition metals is likely to be fundamental to the activity of ascorbate as an essential co-factor for many Fe- and Cu-containing enzymes; in this capacity it ensures that enzyme activity is optimized by the maintenance of t…”
InfluentialMaleki, A., Shahbazi, M., Alinezhad, V., & Santos, H. A. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000248 · Cited by 190
Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT-2
Lv, H., Wang, C., Fang, T., Li, T., Lv, G., Han, Q., Yang, W. K., & Wang, H. (2018) · npj Precision Oncology · doi:10.1038/s41698-017-0044-8 · Cited by 168
The Many Facets of Therapy Resistance and Tumor Recurrence in Glioblastoma
Goenka, A., Tiek, D., Song, X., Huang, T., Hu, B., & Cheng, S.-Y. (2021) · Cells · doi:10.3390/cells10030484 · Cited by 169
High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model
Luchtel, R. A., Bhagat, T. D., Pradhan, K., Jacobs, W. R., Levine, M., Verma, A. K., & Shenoy, N. K. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908158117 · Cited by 171
Self-citationIntravenous vitamin C for reduction of cytokines storm in acute respiratory distress syndrome
Boretti, A. A., & Banik, B. K. (2020) · PharmaNutrition · doi:10.1016/j.phanu.2020.100190 · Cited by 170
Protein oxidation, UVA and human DNA repair
Karran, P., & Brem, R. (2016) · DNA repair · doi:10.1016/j.dnarep.2016.05.024 · Cited by 168
Reactive oxygen species and DNA damage response in cancer
Renaudin, X. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.04.001 · Cited by 172
van Gorkom, G. N. Y., Lookermans, E. L., Van Elssen, C. H. M. J., & Bos, G. M. J. (2019) · Nutrients · doi:10.3390/nu11050977 · Cited by 159
Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers
Tano, M. D., Raucci, F., Vernieri, C., Caffa, I., Buono, R., Fanti, M., Brandhorst, S., Curigliano, G., Nencioni, A., de Braud, F., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16243-3 · Cited by 155
The Role of Iron in Cancer Progression
Guo, Q., Li, L., Hou, S., Yuan, Z., Li, C., Zhang, W., Zheng, L., & Li, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.778492 · Cited by 150
Polireddy, K., Dong, R., Reed, G. A., Yu, J., Chen, P., Williamson, S. K., Violet, P.-C., Pessetto, Z. Y., Godwin, A. K., Fan, F., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17568-8 · Cited by 158
Self-citationMetabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance
Zhou, W., & Wahl, D. R. (2019) · Cancers · doi:10.3390/cancers11091231 · Cited by 152
Implications of reactive oxygen species on cancer formation and its treatment
Shah, M. A., & Rogoff, H. A. (2021) · Seminars in Oncology · doi:10.1053/j.seminoncol.2021.05.002 · Cited by 156
Li, J., Ke, W., Wang, L., Huang, M., Yin, W., Zhang, P., Chen, Q., & Ge, Z. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.029 · Cited by 143
Self-citationIntravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge
Carr, A. C., & Cook, J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01182 · Cited by 133
Oxidatively-generated damage to DNA and proteins mediated by photosensitized UVA
Brem, R., Guven, M., & Karran, P. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.488 · Cited by 139
Schoenfeld, J. D., Sibenaller, Z. A., Mapuskar, K. A., Wagner, B. A., Cramer-Morales, K. L., Furqan, M., Sandhu, S., Carlisle, T. L., Smith, M. C., Hejleh, T. A., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.008 · Cited by 134
Rodríguez‐Fuentes, G., Rubio-Escalante, F. J., Noreña‐Barroso, E., Escalante-Herrera, K. S., & Schlenk, D. (2015) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2015.04.003 · Cited by 131
Alexander, M. S., Wilkes, J. G., Schroeder, S. R., Buettner, G. R., Wagner, B. A., Du, J., Gibson-Corley, K. N., O’Leary, B. R., Spitz, D. R., Buatti, J. M., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1680 · Cited by 129
Intravenous Vitamin C and Cancer: A Systematic Review
Fritz, H., Flower, G., Weeks, L., Cooley, K., Callachan, M., McGowan, J., Skidmore, B., Kirchner, L., & Seely, D. (2014) · Integrative Cancer Therapies · doi:10.1177/1534735414534463 · Cited by 124
Hoffer, L. J., Robitaille, L., ZAKARIAN, R. J., Melnychuk, D., Kavan, P., Agulnik, J. S., Cohen, V., Small, D. I., & Miller, W. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120228 · Cited by 123
Oxidative Stress: A New Target for Pancreatic Cancer Prognosis and Treatment
Martínez‐Useros, J., Li, W., Cabeza-Morales, M., & García‐Foncillas, J. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6030029 · Cited by 127
In-silico Prediction of Synergistic Anti-Cancer Drug Combinations Using Multi-omics Data
Celebi, R., Bear Don’t Walk, O., Movva, R., Alpsoy, S., & Dumontier, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-45236-6 · Cited by 120
Multifunctional Polymeric Micelles with Amplified Fenton Reaction for Tumor Ablation
Wang, Y., Yin, W., Ke, W., Chen, W., He, C., & Ge, Z. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.7b01777 · Cited by 115
Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells
Shenoy, N., Bhagat, T., Nieves, E., Stenson, M., Lawson, J., Choudhary, G. S., Habermann, T., Nowakowski, G., Singh, R., Wu, X., et al. (2017) · Blood Cancer Journal · doi:10.1038/bcj.2017.65 · Cited by 111
Jacobs, C. M., Hutton, B., Ng, T. L., Shorr, R., & Clemons, M. J. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0381 · Cited by 115
Pharmacological Ascorbate Radiosensitizes Pancreatic Cancer
Du, J., Cieslak, J. A., Welsh, J. L., Sibenaller, Z. A., Allen, B. G., Wagner, B. A., Kalen, A. L., Doskey, C. M., Strother, R. K., Button, A. M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1707 · Cited by 112
Chong, Y., Dai, X., Ge, F., Wu, R., Zhao, L., Ma, X., Tian, X., Lee, S., Zhang, C., Chen, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07257-z · Cited by 116
Zhao, H., Zhu, H., Huang, J., Zhu, Y., Hong, M., Zhu, H., Zhang, J., Li, S., Yang, L., Lian, Y., et al. (2018) · Leukemia Research · doi:10.1016/j.leukres.2017.12.009 · Cited by 112
Metabolic interplays between the tumour and the host shape the tumour macroenvironment
Altea‐Manzano, P., Decker-Farrell, A. R., Janowitz, T., & Erez, A. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-024-00786-4 · Cited by 138
Systematic Review of Intravenous Ascorbate in Cancer Clinical Trials
Nauman, G., Gray, J. C., Parkinson, R., Levine, M., & Paller, C. J. (2018) · Antioxidants · doi:10.3390/antiox7070089 · Cited by 107
Self-citationIntravenous vitamin C in the supportive care of cancer patients: A review and rational approach
Klimant, E., Wright, H., Rubin, D., Seely, D., & Markman, M. (2018) · Current Oncology · doi:10.3747/co.25.3790 · Cited by 99
Yasin, B., El‐Fawal, H. A. N., & Mousa, S. A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226210 · Cited by 109
The effect of intravenous vitamin C on cancer- and chemotherapy-related fatigue and quality of life
Carr, A. C., Vissers, M. C. M., & Cook, J. S. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00283 · Cited by 104
Vitamin C as a Modulator of the Response to Cancer Therapy
Błaszczak, W., Barczak, W., Masternak, J., Kopczyński, P., Zhitkovich, A., & Rubiś, B. (2019) · Molecules · doi:10.3390/molecules24030453 · Cited by 104
Epigenetic Regulation of Genomic Stability by Vitamin C
Brabson, J. P., Leesang, T. E., Mohammad, S., & Cimmino, L. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.675780 · Cited by 111
Toyokuni, S. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.401 · Cited by 96
Alterations in Cellular Iron Metabolism Provide More Therapeutic Opportunities for Cancer
Zhou, L., Zhao, B., Zhang, L., Wang, S., Dong, D., Lv, H., & Shang, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051545 · Cited by 102
Nuclear and Cytoplasmic Functions of Vitamin C
Zhitkovich, A. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00348 · Cited by 106
Hedrick, E., Cheng, Y., Jin, U.-H., Kim, K., & Safe, S. H. (2016) · Oncotarget · doi:10.18632/oncotarget.7925 · Cited by 100
The Tumorigenic Roles of the Cellular REDOX Regulatory Systems
Castaldo, S. A., Freitas, J. R., Conchinha, N. V., & Madureira, P. A. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8413032 · Cited by 102
Shenoy, N. K., Bhagat, T. D., Cheville, J. C., Lohse, C. M., Bhattacharyya, S., Tischer, A., Machha, V. R., Gordon-Mitchell, S., Choudhary, G. S., Wong, L.-F., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci98747 · Cited by 97
An, Y., Zhu, J., Liu, F., Deng, J., Meng, X., Liu, G., Wu, H., Fan, A., Wang, Z., & Zhao, Y. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b10954 · Cited by 95
Berretta, M., Quagliariello, V., Maurea, N., Francia, R. D., Sharifi, S., Facchini, G., Rinaldi, L., Piezzo, M., Manuela, C., Nunnari, G., et al. (2020) · Antioxidants · doi:10.3390/antiox9121182 · Cited by 94
Mechanisms of anti-cancer effects of ascorbate: Cytotoxic activity and epigenetic modulation
Mastrangelo, D., Pelosi, E., Castelli, G., Lo‐Coco, F., & Testa, U. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.09.005 · Cited by 89
Vitamin C supplementation in the critically ill patient
Berger, M. M., & Oudemans-van Straaten, H. M. (2015) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0000000000000148 · Cited by 133
Press-pulse: a novel therapeutic strategy for the metabolic management of cancer
Seyfried, T. N., Yu, G. W., Maroon, J. C., & D’Agostino, D. P. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-017-0178-2 · Cited by 86
Ali, T., Li, D., Ponnamperumage, T. N. F., Peterson, A. K., Pandey, J., Fatima, K., Brzezinski, J., Jakusz, J. A. R., Gao, H., Koelsch, G. E., et al. (2024) · Cancers · doi:10.3390/cancers16122171 · Cited by 90
McAdam, E., Brem, R., & Karran, P. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0053 · Cited by 86
Kuang, Y., & Wang, Q. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.08.007 · Cited by 87
Allen, B. G., Bodeker, K. L., Smith, M. C., Monga, V., Sandhu, S., Hohl, R. J., Carlisle, T. L., Brown, H. A., Hollenbeck, N. J., Vollstedt, S., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0594 · Cited by 89
Targeting Cancer Stem Cell Redox Metabolism to Enhance Therapy Responses
Luo, M., & Wicha, M. S. (2018) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2018.10.003 · Cited by 81
Therapeutic Use of Vitamin C in Cancer: Physiological Considerations
Roa, F. J., Peña, E., Gatica, M., Escobar‐Acuña, K., Saavedra, P., Maldonado, M., Cuevas, M. E., Moraga‐Cid, G., Rivas, C. I., & Muñoz-Montesino, C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00211 · Cited by 82
Ma, E., Chen, P., Wilkins, H. M., Wang, T., Swerdlow, R. H., & Chen, Q. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.09.008 · Cited by 79
Self-citationYin, W., Li, J., Ke, W., Zha, Z., & Ge, Z. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b08347 · Cited by 79
Ostriker, A. C., Xie, Y., Chakraborty, R., Sizer, A. J., Bai, Y., Ding, M., Song, W., Huttner, A. J., Hwa, J., & Martin, K. A. (2021) · Circulation · doi:10.1161/circulationaha.120.050553 · Cited by 79
High-Dose Vitamin C for Cancer Therapy
Mussa, A., Idris, R. A. M., Ahmed, N., Ahmad, S., Murtadha, A. H., Din, T. A. D. A. T., Yean, C. Y., Rahman, W. F. W. A., Lazim, N. M., Uskoković, V., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15060711 · Cited by 85
Vitamin C increases 5-hydroxymethylcytosine level and inhibits the growth of bladder cancer
Ding, P., Ge, G., Gong, Y., Zhan, Y., He, S., Guan, B., Li, Y., Xu, Z., Hao, H., He, Z., et al. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0527-7 · Cited by 78
The potential role of vitamin C in empowering cancer immunotherapy
Bedhiafi, T., Inchakalody, V. P., Fernandes, Q., Mestiri, S., Billa, N., Shahab Uddin, M. S., Merhi, M., & Dermime, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112553 · Cited by 77
The role of iron homeostasis and iron-mediated ROS in cancer.
Ying, J., Lu, Z.-B., Fu, L., Tong, Y., Wang, Z., Li, W., & Mou, X. (2021) · PubMed · Cited by 85
Understanding the Therapeutic Potential of Ascorbic Acid in the Battle to Overcome Cancer
Reang, J., Sharma, P. C., Thakur, V. K., & Majeed, J. (2021) · Biomolecules · doi:10.3390/biom11081130 · Cited by 73
Dietary factors and their influence on immunotherapy strategies in oncology: a comprehensive review
Golonko, A., Pienkowski, T., Świsłocka, R., Orzechowska, S., Marszałek, K., Szczerbiński, Ł., Swiergiel, A. H., & Lewandowski, W. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06641-6 · Cited by 77
TET2 as a tumor suppressor and therapeutic target in T-cell acute lymphoblastic leukemia
Bensberg, M., Rundquist, O., Selimović-Pašić, A., Lagerwall, C., Benson, M., Gustafsson, M., Vogt, H., Lentini, A., & Nestor, C. E. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2110758118 · Cited by 70
Ma, Z., Yang, M., Foda, M. F., Zhang, K., Li, S., Liang, H., Zhao, Y., & Han, H. (2022) · ACS Nano · doi:10.1021/acsnano.2c08446 · Cited by 70
Grimm, M. R., Cetindis, M., Lehmann, M., Biegner, T., Munz, A., Teriete, P., Kraut, W., & Reinert, S. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-208 · Cited by 74
GPx3 supports ovarian cancer progression by manipulating the extracellular redox environment
Worley, B. L., Kim, Y. S., Mardini, J., Zaman, R., Leon, K. E., Vallur, P. G., Nduwumwami, A. J., Warrick, J. I., Timmins, P. F., III, Kesterson, J. P., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.11.009 · Cited by 68
Chen, Y., Deng, J., Liu, F., Dai, P., An, Y., Wang, Z., & Zhao, Y. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201900366 · Cited by 70
Dynamics of ascorbic acid content in apple (Malus x domestica) during fruit development and storage
Lemmens, E., Alós, E., Rymenants, M., Storme, N. D., & Keulemans, W. (2020) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2020.03.006 · Cited by 70
High-Dose Vitamin C in Advanced-Stage Cancer Patients
Zasowska‐Nowak, A., Nowak, P. J., & Ciałkowska-Rysz, A. D. (2021) · Nutrients · doi:10.3390/nu13030735 · Cited by 70
Mitochondrial Superoxide Dismutase Has a Protumorigenic Role in Ovarian Clear Cell Carcinoma
Hemachandra, L. P. M. P., Shin, D., Dier, U., Iuliano, J. N., Engelberth, S. A., Uusitalo, L. M., Murphy, S. K., & Hempel, N. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3799 · Cited by 70
The Role of Antioxidants in Cancer, Friends or Foes?
Poljšak, B., & Milisav, I. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190123112647 · Cited by 69
Campbell, E. J., Vissers, M. C. M., Wohlrab, C., Hicks, K. O., Strother, R. M., Bozonet, S. M., Robinson, B. A., & Dachs, G. U. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.08.027 · Cited by 67
Revisiting vitamin C and cancer
Reczek, C. R., & Chandel, N. S. (2015) · Science · doi:10.1126/science.aad8671 · Cited by 67
Low-intensity focused ultrasound-augmented Cascade chemodynamic therapy via boosting ROS generation
Deng, L., Liu, M., Sheng, D., Luo, Y., Wang, D., Yu, X., Wang, Z., Ran, H., & Li, P. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120710 · Cited by 63
Lu, Y., Wu, Q.-N., Chen, D.-L., Chen, L.-Z., Wang, Z., Ren, C., Mo, H., Ya, C., Sheng, H., Wang, Y.-N., et al. (2018) · Theranostics · doi:10.7150/thno.21745 · Cited by 67
Schoenfeld, J. D., Alexander, M. S., Waldron, T. J., Sibenaller, Z. A., Spitz, D. R., Buettner, G. R., Allen, B. G., & Cullen, J. J. (2018) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2018.10.006 · Cited by 68
Multiple Myeloma Tumor Cells are Selectively Killed by Pharmacologically-dosed Ascorbic Acid
Xia, J., Xu, H., Zhang, X., Allamargot, C., Coleman, K. L., Nessler, R., Frech, I., Tricot, G., & Zhan, F. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.02.011 · Cited by 63
Fasting and fasting mimicking diets in cancer prevention and therapy
Blaževitš, O., Tano, M. D., & Longo, V. D. (2023) · Trends in cancer · doi:10.1016/j.trecan.2022.12.006 · Cited by 74
Metadata
- Authors
- Ma, Y., Chapman, J., Levine, M., Polireddy, K., Drisko, J., & Chen, Q.
- Affiliations
- University of Kansas Medical Center (US)
- National Institutes of Health (US)
- Corresponding author
- Drisko, Jeanne
- Chen, Qi
- Venue
- Science Translational Medicine
- Published
- 2014-02-05
- Volume
- 6
- Issue
- 222
- Pages
- 222ra18-222ra18
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2139847043
- Cited by
- 501
- References
- 57
- Citations by year
- 2026: 23 · 2025: 29 · 2024: 44 · 2023: 55 · 2022: 50 · 2021: 51 · 2020: 42 · 2019: 44 · 2018: 53 · 2017: 38 · 2016: 28 · 2015: 23 · 2014: 21
- FWCI
- 34.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- vitamin C, ovarian cancer, chemosensitization, carboplatin, paclitaxel, chemotherapy toxicity, pro-oxidant activity, hydrogen peroxide, DNA damage, ATP depletion, mTOR inhibition, combination therapy, cancer cell death
- MeSH terms
- Animals, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Ascorbic Acid, Disease Models, Animal, Dose-Response Relationship, Drug, Drug Synergism, Female, Humans, Infusions, Parenteral, Ovarian Neoplasms, Carboplatin, Cell Death, Paclitaxel, Xenograft Model Antitumor Assays, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review